![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SANOFI-AVENTIS WITHDRAWS DRONEDARONE EU MARKETING APPLICATION
SANOFI-AVENTIS WITHDRAWS DRONEDARONE EU MARKETING APPLICATION
Sanofi-aventis has withdraw the European application for marketing authorisation of dronedarone, 400 mg film-coated tablets intended for use in the treatment of atrial fibrillation. Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=35012§ionid=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct